Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Depomed Inc Lowers FY 2013 Revenue Guidance


Tuesday, 5 Nov 2013 04:05pm EST 

Depomed Inc revised fiscal 2013 guidance and expects revenue to be in the range of approximately $113 to $116 million. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $115 million for fiscal 2013. 

Company Quote

15.685
0.145 +0.93%
26 Dec 2014